Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.
Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.
复制标题
DOI:
10.1016/j.bmc.2006.02.017
复制
发表时间:
2006-07
影响因子:
3.5
通讯作者:
Ze-Qi Xu;K. Pupek;W. J. Suling;L. Enache;M. Flavin
中科院分区:
文献类型:
--
作者:
Ze-Qi Xu;K. Pupek;W. J. Suling;L. Enache;M. Flavin
Pyranocoumarin compounds were identified to embody a novel and unique pharmacophore for anti-TB activity. A systematic approach was taken to investigate the structural characteristics. Focused libraries of compounds were synthesized and evaluated for their anti-TB activity in primary screening assays. Compounds shown to be active were further determined for MIC and MBC values. Three of the four bactericidal compounds (16, 17c, and 18f) were amino derivatives, with MIC values of 16μg/mL and respective MBC values of 32, 32, and 64μg/mL.